Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill Patients

B. Kurt, L. Buendgens, T.H. Wirtz, S.H. Loosen, M. Schulze-Hagen, D. Truhn, J.F. Brozat, S. Abu Jhaisha, P. Hohlstein, G. Koek, R. Weiskirchen, C. Trautwein, F. Tacke, K. Hamesch, A. Koch*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)

Abstract

Perilipin 2 (PLIN2) is a lipid droplet protein with various metabolic functions. However, studies investigating PLIN2 in the context of inflammation, especially in systemic and acute inflammation, are lacking. Hence, we assessed the relevance of serum PLIN2 in critically ill patients. We measured serum PLIN2 serum in 259 critically ill patients (166 with sepsis) upon admission to a medical intensive care unit (ICU) compared to 12 healthy controls. A subset of 36 patients underwent computed tomography to quantify body composition. Compared to controls, serum PLIN2 concentrations were elevated in critically ill patients at ICU admission. Interestingly, PLIN2 independently indicated multiple organ dysfunction (MOD), defined as a SOFA score > 9 points, at ICU admission, and was also able to independently predict MOD after 48 h. Moreover, serum PLIN2 levels were associated with severe respiratory failure potentially reflecting a moribund state. However, PLIN2 was neither a predictor of ICU mortality nor did it reflect metabolic dysregulation. Conclusively, the first study assessing serum PLIN2 in critical illness proved that it may assist in risk stratification because it is capable of independently indicating MOD at admission and predicting MOD 48 h after PLIN2 measurement. Further evaluation regarding the underlying mechanisms is warranted.
Original languageEnglish
Article number1210
Number of pages21
JournalBiomedicines
Volume9
Issue number9
DOIs
Publication statusPublished - 1 Sep 2021

Keywords

  • sepsis
  • critical illness
  • intensive care unit
  • biomarker
  • SOFA
  • prognosis
  • outcome
  • organ failure
  • DIFFERENTIATION-RELATED PROTEIN
  • LIPID DROPLET PROTEINS
  • ASYMMETRIC DIMETHYLARGININE
  • SKELETAL-MUSCLE
  • FATTY LIVER
  • GENDER-DIFFERENCES
  • HEPATIC STEATOSIS
  • AQUAPORIN 1
  • FOAM CELL
  • ADIPOPHILIN

Cite this